我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

老年慢性心力衰竭患者心脏事件与外周血Adropin水平的相关性及其临床意义

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2018年第4期
页码:
446-448,457
栏目:
临床研究
出版日期:
2018-04-25

文章信息/Info

Title:
Correlation between cardiac events and the level of serum Adropin in elderly patients with chronic heart failure and its clinical significance
作者:
吴 娜1; 周 瑛2; 李 娟1; 罗俊华1; 姜 辉1
（解放军武汉总医院：1.干部病房一科，2.空勤科，湖北 武汉 430070）
Author(s):
WU Na1;  ZHOU Ying2;  LI Juan1;  LUO Jun-hua1;  JIANG Hui1
(1.Department of Geriatrics, 2.Aircrew Department,Wuhan General Hospital of PLA, Wuhan 430070, Hubei, China)
关键词:
心力衰竭; 慢性; Adropin; 预后
Keywords:
heart failure;  chronic;  adropin;  prognosis
分类号:
R541.6
DOI:
-
文献标识码:
A
摘要:
目的 探讨Adropin评估老年慢性心力衰竭（CHF）患者预后的价值。方法 选取老年CHF住院患者60例，入院后常规行超声心动图测量心功能，采用ELISA测定血清Adropin水平。随访12个月，根据随访期内是否发生心脏不良事件分为心脏事件组和非事件组，分析Adropin水平与心脏事件的关系。结果 心脏事件组血清Adropin水平、左室舒张末期内径（LVEDD）、左房内径（LAD）显著高于非事件组（均P<0.05或P<0.01），左室射血分数（LVEF）则低于非事件组（P<0.05）。LAD、Adropin是发生心脏事件的独立相关因素（P<0.05）血清Adropin水平对心力衰竭患者预后判定的受试者工作特征（ROC）曲线下面积为0.830（95%CI：0.724~0.936，P<0.01），符合预测心脏事件的条件。当截断值为11.84 ng/ml时，其敏感度73%，特异性83%。结论 CHF患者血清Adropin水平与心血管事件发生率有相关性，对于预测老年CHF患者发生心血管事件具有一定的临床价值。
Abstract:
AIM To investigate the prognostic value of Adropin in elderly patients with chronic heart failure (CHF). METHODS A total of 60 patients with heart failure were enrolled in the study. Cardiac function was determined by echocardiography after admission. Serum Adropin was determined by enzyme-linked immunosorbent assay (ELISA). The patients were followed for 12 months. According to the incidence of adverse cardiac events, the patients were divided into two groups: a cardiac event group and a non-event group. The relationship between the levels of serum Adropin and cardiac events was analyzed. RESULTS The levels of serum Adropin, LVEDD, LAD in the cardiac event group were significantly higher than the non-event group (P<0.05 or P<0.01). LVEF levels were lower than that in the non-event group (P<0.05) . LAD, Adropin were an independent risk factor for cardiac events (P<0.05). The area under ROC curve for predicting the prognosis of heart failure patients by seurm Adropin was 0.830 (95%CI: 0.724-0.936, P=0.000), complying with prognostic condition for cardiac event. When the cutoff value of Adropin was 11.84 ng/ml, the sensitivity and specificity were 73% and 83%, respectively. The incidence of cardiac adverse events (86%, 24/28) in the high Adropin group was significantly higher than that (32%, 9/28) in the low Adropin group (P<0.01). CONCLUSION Serum Adropin levels in CHF patients are associated with cardiovascular events. There is a certain clinical value on the recurrence of cardiovascular events for serum Adropin in patients with CHF.

参考文献/References

[1]赵玉清,袁桂莉,张进顺,等.和肽素联合N末端B型利钠肽原评估慢性心力衰竭患者预后的价值[J].中国循环杂志,2014,29(4):275-278.

[2]Kumar KG,Trevaskis JL,Lam DD,et al.Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism[J].Cell Metab,2008,8(6):468-481.

[3]张亚南,李安荣,陈旭东,等.adropin蛋白的研究进展及临床意义[J].医学综述,2016,22(1):20-23.

[4]梁 鹏,张松飞,王 珂,等. 胰岛素抵抗与心力衰竭关系的研究进展[J].心脏杂志,2016,28(3):352-355.

[5]Yosaee S,Soltani S,Sekhavati E,et al.Adropin- A Novel Biomarker of Heart Disease:A Systematic Review Article[J].Iran J Public Health,2016,45(12):1568-1576.

[6]中华医学会心血管病分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断与治疗指南2014[J].中华心血管病杂志,2014,42(2):98-122.

[7]Ziaeian B,Fonarow GC. Epidemiology and aetiology of heart failure[J].Nat Rev Cardiol,2016,13(6):368-378.

[8]Lopes LR,Elliott PM.Genetics of heart failure[J].Biochim Biophys Acta,2013,1832(12):2451-2461.

[9]Lovren F,Pan Y,Quan A,et al.Adropin is a novel regulator of endothelial function[J].Circulation,2010,122(11Suppl):S185-192.

[10]Kim JA,Montagnani M,Koh KK,et al.Reciprocal relationships between insulin resistance and endothelial dysfunction:molecular and pathophysiological mechanisms[J].Circulation,2006,113(15):1888-904.

[11]Kathir K,Adams MR.Endothelial dysfunction as a predictor of acute coronary syndromes[J].Semin Vasc Med,2003,3(4):355-362.

[12]Wu L,Fang J,Chen L,et al.Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients[J].Clin Chem Lab Med,2014,52(5):751-758.

[13]穆 展,吴志红,闫书彩,等.急性冠脉综合征患者血清Adropin水平变化及意义[J].中日友好医院学报,2014,28(5):273-276.

[14]张诚佳,赵良平,徐卫亭,等.血清Adropin水平与冠状动脉支架内再狭窄的关系[J].中国动脉硬化杂志,2014,22(11):1123-1126.

[15]Yu HY,Zhao P,Wu MC,et al.Serum adropin levels are decreased in patients with acute myocardial infarction[J].Regul Pept,2014,(190-191):46-49.

[16]Aydin S,Eren MN,Yilmaz M,et al.Adropin as a potential marker of enzyme-positive acute coronary syndrome[J].Cardiovasc J Afr,2017,28(1):40-47.

[17]余 健,王琰,俞叶军.血浆Adropin水平与急性心肌梗死患者心功能关系的相关性研究[J].心电与循环,2013,32(6):489-490.

[18]Lian W,Gu X,Qin Y,et al.Elevated plasma levels of adropin in heart failure patients[J].Intern Med,2011,50(15):1523-1527.

备注/Memo

备注/Memo:
收稿日期：2017-03-11.作者简介：吴娜，主治医师 Email：1984413633@qq.com
更新日期/Last Update: 1900-01-01